Literature DB >> 11500471

PcrV immunization enhances survival of burned Pseudomonas aeruginosa-infected mice.

I A Holder1, A N Neely, D W Frank.   

Abstract

Burned Pseudomonas aeruginosa-infected mice immunized against PcrV, a type III virulence system translocating protein, showed significantly enhanced survival compared to controls. Survival was non-O serotype specific and correlated with a reduced systemic microbial load. Infection with a high-level toxin A-producing strain required supplemental antitoxin treatment to enhance survival.

Entities:  

Mesh：

Substances：

Year:  2001        PMID： 11500471      PMCID： PMC98711          DOI： 10.1128/IAI.69.9.5908-5910.2001

Source DB:  PubMed          Journal:  Infect Immun        ISSN： 0019-9567            Impact factor:   3.441


  13 in total

Review 1.  The Yersinia deadly kiss.

Authors:  G R Cornelis
Journal:  J Bacteriol       Date:  1998-11       Impact factor: 3.490

Review 2.  Type III protein secretion systems in bacterial pathogens of animals and plants.

Authors:  C J Hueck
Journal:  Microbiol Mol Biol Rev       Date:  1998-06       Impact factor: 11.056

Review 3.  Type III secretion systems: machines to deliver bacterial proteins into eukaryotic cells?

Authors:  C A Lee
Journal:  Trends Microbiol       Date:  1997-04       Impact factor: 17.079

4.  Passive protection by antitoxin in experimental Pseudomonas aeruginosa burn infections.

Authors:  O R Pavlovskis; M Pollack; L T Callahan; B H Iglewski
Journal:  Infect Immun       Date:  1977-12       Impact factor: 3.441

5.  Active and passive immunization with the Pseudomonas V antigen protects against type III intoxication and lung injury.

Authors:  T Sawa; T L Yahr; M Ohara; K Kurahashi; M A Gropper; J P Wiener-Kronish; D W Frank
Journal:  Nat Med       Date:  1999-04       Impact factor: 53.440

6.  Exoenzyme S of Pseudomonas aeruginosa is secreted by a type III pathway.

Authors:  T L Yahr; J Goranson; D W Frank
Journal:  Mol Microbiol       Date:  1996-12       Impact factor: 3.501

Review 7.  The exoenzyme S regulon of Pseudomonas aeruginosa.

Authors:  D W Frank
Journal:  Mol Microbiol       Date:  1997-11       Impact factor: 3.501

8.  Experimental studies of the pathogenesis of infections due to Pseudomonas aeruginosa: description of a burned mouse model.

Authors:  D D Stieritz; I A Holder
Journal:  J Infect Dis       Date:  1975-06       Impact factor: 5.226

9.  Role of exotoxin and protease as possible virulence factors in experimental infections with Pseudomonas aeruginosa.

Authors:  K Snell; I A Holder; S A Leppla; C B Saelinger
Journal:  Infect Immun       Date:  1978-03       Impact factor: 3.441

10.  Genetic relationship between the 53- and 49-kilodalton forms of exoenzyme S from Pseudomonas aeruginosa.

Authors:  T L Yahr; J T Barbieri; D W Frank
Journal:  J Bacteriol       Date:  1996-03       Impact factor: 3.490
View more
  33 in total

1.  Orientation of Pseudomonas aeruginosa ExsA monomers bound to promoter DNA and base-specific contacts with the P(exoT) promoter.

Authors:  Jessica M King; Evan D Brutinel; Anne E Marsden; Florian D Schubot; Timothy L Yahr
Journal:  J Bacteriol       Date:  2012-03-09       Impact factor: 3.490

2.  Type III secretion-dependent modulation of innate immunity as one of multiple factors regulated by Pseudomonas aeruginosa RetS.

Authors:  Irandokht Zolfaghar; David J Evans; Reza Ronaghi; Suzanne M J Fleiszig
Journal:  Infect Immun       Date:  2006-07       Impact factor: 3.441

3.  Immunization with 3-oxododecanoyl-L-homoserine lactone-r-PcrV conjugate enhances survival of mice against lethal burn infections caused by Pseudomonas aeruginosa.

Authors:  Isar Dejban Golpasha; Seyed Fazlollah Mousavi; Parviz Owlia; Seyed Davar Siadat; Shiva Irani
Journal:  Bosn J Basic Med Sci       Date:  2015-05-25       Impact factor: 3.363

4.  Induced conformational changes in the activation of the Pseudomonas aeruginosa type III toxin, ExoU.

Authors:  Marc A Benson; Steven M Komas; Katherine M Schmalzer; Monika S Casey; Dara W Frank; Jimmy B Feix
Journal:  Biophys J       Date:  2011-03-02       Impact factor: 4.033

Review 5.  Recent developments for Pseudomonas vaccines.

Authors:  Anurag Sharma; Anja Krause; Stefan Worgall
Journal:  Hum Vaccin       Date:  2011-10-01

6.  A novel anti-PcrV antibody providing enhanced protection against Pseudomonas aeruginosa in multiple animal infection models.

Authors:  Paul Warrener; Reena Varkey; Jessica C Bonnell; Antonio DiGiandomenico; Maria Camara; Kimberly Cook; Li Peng; Jingying Zha; Partha Chowdury; Bret Sellman; C Kendall Stover
Journal:  Antimicrob Agents Chemother       Date:  2014-05-19       Impact factor: 5.191

7.  Self-association is required for occupation of adjacent binding sites in Pseudomonas aeruginosa type III secretion system promoters.

Authors:  Anne E Marsden; Florian D Schubot; Timothy L Yahr
Journal:  J Bacteriol       Date:  2014-07-28       Impact factor: 3.490

8.  The prophylactic effects of human IgG derived from sera containing high anti-PcrV titers against pneumonia-causing Pseudomonas aeruginosa.

Authors:  Mao Kinoshita; Hideya Kato; Hiroaki Yasumoto; Masaru Shimizu; Saeko Hamaoka; Yoshifumi Naito; Koichi Akiyama; Kiyoshi Moriyama; Teiji Sawa
Journal:  Hum Vaccin Immunother       Date:  2016-07-25       Impact factor: 3.452

9.  Oligomerization of PcrV and LcrV, protective antigens of Pseudomonas aeruginosa and Yersinia pestis.

Authors:  Caroline Gébus; Gébus Caroline; Eric Faudry; Faudry Eric; Yu-Sing Tammy Bohn; Sylvie Elsen; Elsen Sylvie; Ina Attree
Journal:  J Biol Chem       Date:  2008-06-26       Impact factor: 5.157

10.  Biophysical characterization of Chlamydia trachomatis CT584 supports its potential role as a type III secretion needle tip protein.

Authors:  Aaron P Markham; Zane A Jaafar; Kyle E Kemege; C Russell Middaugh; P Scott Hefty
Journal:  Biochemistry       Date:  2009-11-03       Impact factor: 3.162
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.